New Results
Currently available intravenous immunoglobulin (Gamunex®-C and Flebogamma® DIF) contains antibodies reacting against SARS-CoV-2 antigens
José-María Díez, Carolina Romero, Rodrigo Gajardo
doi: https://doi.org/10.1101/2020.04.07.029017
José-María Díez
Research and Development – Bioscience Industrial Group, Grifols, Barcelona, Spain
Carolina Romero
Research and Development – Bioscience Industrial Group, Grifols, Barcelona, Spain
Rodrigo Gajardo
Research and Development – Bioscience Industrial Group, Grifols, Barcelona, Spain
Article usage
Posted April 16, 2020.
Currently available intravenous immunoglobulin (Gamunex®-C and Flebogamma® DIF) contains antibodies reacting against SARS-CoV-2 antigens
José-María Díez, Carolina Romero, Rodrigo Gajardo
bioRxiv 2020.04.07.029017; doi: https://doi.org/10.1101/2020.04.07.029017
Subject Area
Subject Areas
- Biochemistry (11573)
- Bioengineering (8623)
- Bioinformatics (28875)
- Biophysics (14805)
- Cancer Biology (11944)
- Cell Biology (17170)
- Clinical Trials (138)
- Developmental Biology (9307)
- Ecology (14022)
- Epidemiology (2067)
- Evolutionary Biology (18129)
- Genetics (12148)
- Genomics (16619)
- Immunology (11712)
- Microbiology (27702)
- Molecular Biology (11401)
- Neuroscience (60106)
- Paleontology (448)
- Pathology (1849)
- Pharmacology and Toxicology (3184)
- Physiology (4878)
- Plant Biology (10279)
- Synthetic Biology (2849)
- Systems Biology (7291)
- Zoology (1619)